Pyschiatric Advance Directives Effective for Mental Disorders

MONDAY, Aug. 22, 2022 (HealthDay News) -- Peer worker-facilitated psychiatric advance directives (PW-PAD) are effective for decreasing compulsory hospital admissions among people with mental disorders, according to a study recently published in JAMA Psychiatry.
Aurélie Tinland, M.D., Ph.D., from Aix-Marseille University in France, and colleagues determined the efficacy of PW-PAD in mental disorders in a multicenter randomized clinical trial. Adults with a diagnosis of schizophrenia, bipolar I disorder, or schizoaffective disorder who had a compulsory admission in the past 12 months were enrolled. The primary outcome was the rate of compulsory admission 12 months after randomization in 394 participants (196 assigned to the PW-PAD group and 198 to the control group).
The researchers found that 27.0 and 39.9 percent of participants in the PW-PAD and control groups, respectively, had compulsory admissions. There were no significant differences observed between the groups in the rate of overall admission, therapeutic alliance score, or quality of life. Fewer symptoms, greater empowerment, and a higher recovery score were seen for participants in the PW-PAD group versus the control group (effect sizes, 0.20, 0.30, and 0.44, respectively).
"These findings support the use of PW-PADs for people with schizophrenia, bipolar I disorder, or schizoaffective disorder," the authors write. "Legal and organizational initiatives that promote supported decision making can develop the activity of peer workers to fulfill this mission."
Related Posts
Incidence Rate of Diagnosed Vitiligo 22.6 per 100,000 Person-Years
MONDAY, July 24, 2023 (HealthDay News) -- Vitiligo diagnosis is more common in...
Más estadounidenses están muriendo de enfermedad de Parkinson, según un estudio
JUEVES, 28 de octubre de 2021 (HealthDay News) -- El número de estadounidenses...
Walgreens Will Not Sell Abortion Pills in 20 Republican States
MONDAY, March 6, 2023 (HealthDay News) – After receiving a warning letter from...
Dexamethasone Best for Persistent, Recurrent Uveitic Macular Edema
THURSDAY, June 22, 2023 (HealthDay News) -- For patients with minimally active...
